MENTANINE Trademark

Trademark Overview

On Tuesday, July 19, 2022, a trademark application was filed for MENTANINE with the United States Patent and Trademark Office. The USPTO has given the MENTANINE trademark a serial number of 97509439. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, May 31, 2025. This trademark is owned by CanaQuest Medical Corp.. The MENTANINE trademark is filed in the Pharmaceutical Products category with the following description:

Amino acid preparations containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis for medical purposes
mentanine

General Information

Serial Number97509439
Word MarkMENTANINE
Filing DateTuesday, July 19, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, May 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2023

Trademark Statements

Goods and ServicesAmino acid preparations containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2022
Primary Code005
First Use Anywhere DateFriday, September 2, 2022
First Use In Commerce DateFriday, September 2, 2022

Trademark Owner History

Party NameCanaQuest Medical Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5L5S9
CA
Party NameCanaQuest Medical Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5L5S9
CA

Trademark Events

Event DateEvent Description
Friday, July 22, 2022NEW APPLICATION ENTERED
Friday, May 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 4, 2023ASSIGNED TO EXAMINER
Tuesday, June 13, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 6, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, October 22, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, June 13, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 4, 2024USE AMENDMENT FILED
Tuesday, June 4, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 4, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 4, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, July 18, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 18, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 5, 2024ASSIGNED TO EXAMINER
Thursday, September 12, 2024ASSIGNED TO EXAMINER
Tuesday, June 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 17, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, September 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2024NON-FINAL ACTION E-MAILED
Tuesday, December 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 16, 2025ASSIGNED TO LIE
Tuesday, February 4, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 4, 2025SU - FINAL REFUSAL - WRITTEN
Thursday, January 16, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 4, 2025FINAL REFUSAL E-MAILED
Saturday, May 31, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, May 31, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

mentanine than more concentration percent weight purposes medical basis tetrahydrocannabinol delta